产品说明
一般描述
OMPT is a selective agonist of the LPA3 receptor. It exhibits EC50 values of 68 nM and >6.8 μM for calcium mobilization in LPA3 and LPA2-expressing Sf9 cells, respectively. The (2S)-OMPT enantiomer is 5- to 20-fold more active than (2R)-OMPT in calcium release assays in both LPA3-transfected Sf9 and rat hepatoma Rh7777 cells.
应用
(2S)-OMPT may be used:
- to study its effects on lysophosphatidic acid receptor-3 (LPAR3) receptor
- to pre-incubate hepatocytes and also characterize the role of LPAR3 on insulin-cascade
- as an analog of LPA to study its effects on tube stability of 10T cells
包装
2 mL Amber Serum Vial with Stopper and Crimp Cap (857235P-500ug)
2 mL Amber Serum Vial with Stopper and Crimp Cap (857235P-1mg)
基本信息
经验(实验)分子式 | C22H46NO6PS |
分子量 | 483.64 |
产品性质
测定 | >99% (TLC) |
形式 | powder |
包装 | package of 1 × 1 mg ((857235P-1mg)) package of 1 × 500 μg ((857235P-500ug)) |
manufacturer/tradename | Avanti Polar Lipids 857235P |
运输 | dry ice |
储存温度 | −20℃ |
SMILES string | [H][C@](COP([O-])(O)=S)(OC)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+] |
安全信息
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 3 |
闪点(F) | 49.5 °F - closed cup |
闪点(C) | 9.7 ℃ - closed cup |